Cited by 28Contact Dermatitis and AllergiesDermatology and Skin DiseasesNail Diseases and Treatments

The efficacy of ‘0.05% Clobetasol + 2.5% zinc sulphate’ cream vs. ‘0.05% Clobetasol alone’ cream in the treatment of the chronic hand eczema: a double‐blind study

Faghihi, G, Iraji, F, Shahingohar, A, Saidat, AH·2008·Journal of the European Academy of Dermatology and Venereology

Abstract

BACKGROUND: Many therapeutic modalities have been suggested for treatment of the chronic hand eczema. Despite good immediate efficacy of some of these treatments, there is high recurrence of the dermatitis following cessation of the treatment. AIM: Regarding the beneficial effects of the zinc sulfate on the skin, we designed a double blind study to evaluate the efficacy of the '0.05% Clobetasol + 2.5% zinc sulphate' cream versus '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema. SUBJECTS AND METHODS: This study was a double-blind, right to left, prospective, clinical trial. In total, 47 patients with chronic hand eczema admitted to dermatology center of Isfahan University of Medical Sciences were selected and their right hand or left hand were selected at random to be treated with either the '0.05% Clobetasol + 2.5% zinc sulphate' cream or '0.05% Clobetasol alone' cream twice daily for 2 weeks. All of the patients were treated for 2 weeks and were followed up at weeks 2, 4, 6 and 8 after starting the treatment. For determining the severity of chronic hand eczema, we assessed and scored 4 different characteristics of the lesions including redness; scaling; lichenification and pruritus. The data were analyzed using SPSS program (release 13) and statistical tests including Mann-Whitney test. RESULTS: Overall, 47 patients (94 samples) were evaluated. All of these patients had similar and symmetrical lesions on their right and left hands. Out of them, 35 patients were females and 12 patients were male. In all of the evaluated characterisitics, the '0.05% Clobetasol + 2.5% zinc sulphate' cream was more effective than '0.05% Clobetasol alone' cream (P < 0.05). The recurrence rate of eczema was significantly lower in the group treated with this combination treatment (P < 0.05). CONCLUSION: With regard to the encouraging results of the combination treatment with Clobetasol + zinc sulphate, we suggest that in a more extensive clinical trial, the efficacy of this treatment against chronic hand dermatitis be evaluated. In addition, evaluation of this combination therapy against other inflammatory dermatosis seems to be logical.

Integrity signals

Registry

Crossref · 10.1111/j.1468-3083.2007.02533.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A 0.05% Clobetasol + 2.5% zinc sulphate cream applied topically was effective in hand eczemas.

    “eczema (a 0.05% Clobetasol + 2.5% zinc sulphate cream applied topically was effective in hand eczemas) [115]”

    From Bioactive Compounds for Skin Health: A Review (2021) · cites this paper as [115]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Faghihi, G., Iraji, F., Shahingohar, A., & Saidat, A.
Affiliations
Isfahan University of Medical Sciences (IR)
Corresponding author
Saidat, AH
Venue
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Published
2008-02-14
Volume
22
Issue
5
Pages
531-536
ISSN
  • 0926-9959 (ISSN-L)
  • 1468-3083
OpenAlex
W2059033645
Cited by
28
References
9
Citations by year
2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 1 · 2017: 2 · 2016: 2 · 2014: 1
FWCI
4.27
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the European Academy of Dermatology and Venereology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Isfahan University of Medical Sciences
Topics
  • Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Epidemiology › Nail Diseases and Treatments
Keywords
chronic hand eczema, clobetasol, zinc sulfate, topical combination therapy, corticosteroid cream, lichenification, pruritus, recurrence rate, combination therapy efficacy
MeSH terms
Administration, Topical, Adolescent, Adult, Aged, Aged, 80 and over, Astringents, Child, Chronic Disease, Clobetasol, Double-Blind Method, Drug Therapy, Combination, Eczema, Female, Glucocorticoids, Hand, Humans, Male, Middle Aged, Ointments, Prospective Studies, Recurrence, Severity of Illness Index, Zinc Sulfate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review